T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

Evaxion Biotech AS (EVAX) stock has reached a new 52-week low, touching down at $3.06, with InvestingPro data showing the stock's RSI indicating oversold territory. The company faces a challenging ...

The authors present new expression analysis software (TEKRABber) to help analyze expression correlations between transposable elements (TEs) and KRAB zinc finger (KRAB-ZNF) genes in experimentaly ...

Trailhead Biosystems, a pioneering biotechnology company specializing in the development of iPSC-derived human cells for drug discovery and cell therapy, is pleased to announce the appointment of Dr.

1 Section of Virology, Department of Infectious Disease, Imperial College London, London, United Kingdom 2 National Centre for Human Retrovirology, Division of Medicine and Integrated Care, St. Mary's ...

Hervolution Therapeutics ApS (formerly Inprother Aps) has announced a $11.7 million series A financing to support its work developing novel human endogenous retrovirus (HERV)-targeted immunotherapies ...

The Market research collection of Report Ocean has recently included the “Saudi Arabia Immunodiagnostic Market” Size, Scope, and Forecast 2024-2032 report. This report, prepared by industry experts ...

These illnesses are life-threatening to people with HIV.The CDC lists 27 different AIDS-defining conditions in people with ...